 Robert Enzenauer
Concepts (543)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amblyopia | 7 | 2023 | 60 | 1.700 |
Why?
| | Ophthalmologic Surgical Procedures | 8 | 2019 | 90 | 1.450 |
Why?
| | Vision Screening | 4 | 2023 | 48 | 1.420 |
Why?
| | Retinopathy of Prematurity | 9 | 2021 | 179 | 1.330 |
Why?
| | Strabismus | 9 | 2017 | 71 | 1.180 |
Why?
| | Refractive Errors | 4 | 2023 | 36 | 1.160 |
Why?
| | Oculomotor Muscles | 11 | 2017 | 84 | 1.080 |
Why?
| | Cornea | 9 | 2021 | 155 | 1.070 |
Why?
| | Ophthalmology | 6 | 2021 | 116 | 0.800 |
Why?
| | Eye Injuries, Penetrating | 3 | 2013 | 19 | 0.760 |
Why?
| | Military Medicine | 4 | 2016 | 149 | 0.670 |
Why?
| | Eye Injuries | 8 | 2016 | 53 | 0.670 |
Why?
| | Eye Foreign Bodies | 3 | 2014 | 23 | 0.660 |
Why?
| | Military Personnel | 8 | 2018 | 741 | 0.650 |
Why?
| | Photography | 3 | 2010 | 115 | 0.630 |
Why?
| | Endophthalmitis | 5 | 2002 | 45 | 0.610 |
Why?
| | Chemical Warfare Agents | 6 | 2021 | 104 | 0.610 |
Why?
| | Patient Simulation | 1 | 2019 | 41 | 0.570 |
Why?
| | Exotropia | 4 | 2006 | 25 | 0.570 |
Why?
| | Lighting | 2 | 2016 | 30 | 0.560 |
Why?
| | Tensile Strength | 2 | 2017 | 96 | 0.550 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.540 |
Why?
| | Equipment Design | 1 | 2019 | 530 | 0.510 |
Why?
| | Eye Infections, Bacterial | 3 | 2002 | 44 | 0.490 |
Why?
| | Teaching | 1 | 2019 | 236 | 0.490 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.480 |
Why?
| | Esotropia | 4 | 2006 | 27 | 0.480 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2016 | 53 | 0.480 |
Why?
| | Color Vision | 1 | 2016 | 4 | 0.470 |
Why?
| | Wound Healing | 3 | 2017 | 351 | 0.460 |
Why?
| | Color | 1 | 2016 | 81 | 0.460 |
Why?
| | Neonatal Screening | 5 | 2021 | 178 | 0.430 |
Why?
| | Delivery of Health Care | 2 | 2013 | 947 | 0.420 |
Why?
| | Boxing | 5 | 1994 | 7 | 0.410 |
Why?
| | Ophthalmic Solutions | 5 | 2017 | 79 | 0.400 |
Why?
| | Tissue Adhesions | 2 | 2017 | 34 | 0.400 |
Why?
| | Humans | 117 | 2023 | 144759 | 0.380 |
Why?
| | Vitrectomy | 4 | 2007 | 73 | 0.380 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 270 | 0.380 |
Why?
| | Visual Acuity | 11 | 2013 | 489 | 0.370 |
Why?
| | Retinoscopes | 1 | 2011 | 1 | 0.340 |
Why?
| | Rabbits | 8 | 2021 | 648 | 0.330 |
Why?
| | Insurance, Liability | 1 | 2010 | 8 | 0.330 |
Why?
| | Dacryocystitis | 1 | 2010 | 3 | 0.330 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.320 |
Why?
| | Nonprescription Drugs | 2 | 2003 | 65 | 0.320 |
Why?
| | Mustard Gas | 3 | 2021 | 93 | 0.310 |
Why?
| | Pupil Disorders | 1 | 2010 | 7 | 0.310 |
Why?
| | Corneal Injuries | 2 | 2021 | 42 | 0.310 |
Why?
| | Reimbursement Mechanisms | 1 | 2010 | 80 | 0.310 |
Why?
| | Infant, Newborn | 27 | 2021 | 6429 | 0.310 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 23 | 0.300 |
Why?
| | Warfare | 3 | 2018 | 101 | 0.290 |
Why?
| | Sensitivity and Specificity | 6 | 2023 | 1985 | 0.290 |
Why?
| | Mechlorethamine | 3 | 2019 | 53 | 0.280 |
Why?
| | Decompression, Surgical | 3 | 2019 | 116 | 0.280 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 6048 | 0.280 |
Why?
| | Corneal Neovascularization | 3 | 2017 | 15 | 0.270 |
Why?
| | Vitreous Detachment | 1 | 2007 | 6 | 0.270 |
Why?
| | Developmental Disabilities | 1 | 2011 | 281 | 0.270 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2007 | 31 | 0.260 |
Why?
| | Optic Disk | 1 | 2007 | 53 | 0.260 |
Why?
| | Vitreous Body | 1 | 2007 | 117 | 0.250 |
Why?
| | Arsenicals | 2 | 2017 | 28 | 0.250 |
Why?
| | Circumcision, Male | 5 | 1987 | 16 | 0.250 |
Why?
| | Birth Weight | 5 | 2017 | 522 | 0.250 |
Why?
| | Weight Gain | 3 | 2016 | 556 | 0.240 |
Why?
| | Photorefractive Keratectomy | 1 | 2006 | 21 | 0.240 |
Why?
| | Horner Syndrome | 1 | 2006 | 7 | 0.240 |
Why?
| | Orbit | 3 | 2013 | 64 | 0.240 |
Why?
| | Choristoma | 1 | 2006 | 21 | 0.230 |
Why?
| | Infant | 25 | 2017 | 10034 | 0.230 |
Why?
| | Indans | 1 | 2005 | 13 | 0.230 |
Why?
| | Corneal Transplantation | 2 | 2005 | 17 | 0.230 |
Why?
| | Nootropic Agents | 1 | 2005 | 30 | 0.230 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2005 | 23 | 0.230 |
Why?
| | Neck | 1 | 2006 | 108 | 0.230 |
Why?
| | Hypergammaglobulinemia | 2 | 1999 | 8 | 0.230 |
Why?
| | Retinal Hemorrhage | 5 | 2013 | 21 | 0.220 |
Why?
| | Cataract Extraction | 3 | 2002 | 119 | 0.220 |
Why?
| | Keratomileusis, Laser In Situ | 1 | 2005 | 20 | 0.220 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2115 | 0.220 |
Why?
| | Thymus Gland | 1 | 2006 | 311 | 0.220 |
Why?
| | Mathematical Computing | 1 | 2004 | 11 | 0.210 |
Why?
| | Vitamin A Deficiency | 1 | 2004 | 26 | 0.210 |
Why?
| | Ocular Motility Disorders | 2 | 2003 | 41 | 0.210 |
Why?
| | Contact Lenses, Hydrophilic | 2 | 1997 | 6 | 0.210 |
Why?
| | Multiple Sclerosis | 1 | 2010 | 484 | 0.210 |
Why?
| | Orbital Fractures | 1 | 2004 | 14 | 0.210 |
Why?
| | Retinal Detachment | 2 | 2002 | 72 | 0.200 |
Why?
| | Vision, Ocular | 2 | 2016 | 47 | 0.200 |
Why?
| | Child | 17 | 2023 | 22633 | 0.200 |
Why?
| | Piperidines | 1 | 2005 | 217 | 0.200 |
Why?
| | Corneal Diseases | 2 | 2015 | 46 | 0.200 |
Why?
| | Diplopia | 1 | 2003 | 27 | 0.190 |
Why?
| | Suture Techniques | 3 | 1999 | 131 | 0.190 |
Why?
| | Dry Eye Syndromes | 1 | 2003 | 56 | 0.190 |
Why?
| | Eyelids | 3 | 2013 | 41 | 0.180 |
Why?
| | Risk Factors | 9 | 2023 | 10779 | 0.180 |
Why?
| | Astigmatism | 2 | 2011 | 17 | 0.180 |
Why?
| | Intraocular Pressure | 6 | 2013 | 328 | 0.180 |
Why?
| | Drug Costs | 1 | 2003 | 116 | 0.180 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3409 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2003 | 239 | 0.180 |
Why?
| | Physical Examination | 1 | 2023 | 239 | 0.180 |
Why?
| | Granuloma, Foreign-Body | 1 | 2002 | 8 | 0.180 |
Why?
| | Blepharoptosis | 1 | 2002 | 12 | 0.180 |
Why?
| | Sclerostomy | 1 | 2001 | 4 | 0.180 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2002 | 14 | 0.180 |
Why?
| | Abducens Nerve Diseases | 1 | 2002 | 13 | 0.180 |
Why?
| | Myopia | 2 | 2011 | 59 | 0.170 |
Why?
| | Male | 54 | 2020 | 72315 | 0.170 |
Why?
| | Epithelium, Corneal | 3 | 2017 | 41 | 0.170 |
Why?
| | Female | 47 | 2017 | 78271 | 0.170 |
Why?
| | Echolalia | 1 | 2001 | 1 | 0.170 |
Why?
| | Vigabatrin | 1 | 2021 | 19 | 0.170 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.170 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2001 | 14 | 0.170 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 21 | 0.170 |
Why?
| | Hospitalization | 3 | 2010 | 2433 | 0.170 |
Why?
| | Child, Preschool | 17 | 2020 | 11787 | 0.160 |
Why?
| | Trabeculectomy | 1 | 2001 | 75 | 0.160 |
Why?
| | Tissue Donors | 2 | 2005 | 424 | 0.160 |
Why?
| | Arthritis | 3 | 2017 | 96 | 0.160 |
Why?
| | Codon, Nonsense | 1 | 2020 | 44 | 0.160 |
Why?
| | Immunoglobulin G | 2 | 1999 | 893 | 0.160 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 153 | 0.160 |
Why?
| | Retinal Diseases | 5 | 1994 | 101 | 0.160 |
Why?
| | Eye Proteins | 1 | 2020 | 90 | 0.160 |
Why?
| | Cyclooxygenase 2 | 5 | 2021 | 165 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2001 | 104 | 0.160 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1326 | 0.160 |
Why?
| | Scleral Buckling | 1 | 1999 | 16 | 0.160 |
Why?
| | Drug Residues | 1 | 1999 | 5 | 0.150 |
Why?
| | Leadership | 1 | 2004 | 408 | 0.150 |
Why?
| | Wilms Tumor | 1 | 2020 | 85 | 0.150 |
Why?
| | Sclera | 1 | 1999 | 38 | 0.150 |
Why?
| | Corneal Stroma | 2 | 2017 | 24 | 0.150 |
Why?
| | Organ Preservation Solutions | 1 | 1999 | 47 | 0.150 |
Why?
| | Prospective Studies | 7 | 2019 | 7990 | 0.150 |
Why?
| | Lacrimal Apparatus | 1 | 2019 | 9 | 0.150 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 1999 | 9 | 0.150 |
Why?
| | Paraproteinemias | 1 | 1999 | 5 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4557 | 0.150 |
Why?
| | Retinal Vein Occlusion | 1 | 1999 | 14 | 0.150 |
Why?
| | Functional Laterality | 2 | 2010 | 241 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2021 | 235 | 0.140 |
Why?
| | Face | 1 | 2020 | 173 | 0.140 |
Why?
| | Pneumococcal Infections | 1 | 1999 | 103 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2017 | 2919 | 0.140 |
Why?
| | Staphylococcal Infections | 3 | 2011 | 388 | 0.140 |
Why?
| | Contrast Sensitivity | 1 | 2018 | 15 | 0.140 |
Why?
| | Vision Tests | 1 | 2018 | 22 | 0.140 |
Why?
| | Color Perception | 1 | 2018 | 25 | 0.140 |
Why?
| | Organ Preservation | 1 | 1999 | 130 | 0.140 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2021 | 132 | 0.140 |
Why?
| | United States | 13 | 2021 | 15966 | 0.140 |
Why?
| | Naphazoline | 1 | 1997 | 1 | 0.140 |
Why?
| | Pheniramine | 1 | 1997 | 1 | 0.140 |
Why?
| | Retrobulbar Hemorrhage | 2 | 2009 | 4 | 0.140 |
Why?
| | Conjunctivitis, Allergic | 1 | 1997 | 4 | 0.140 |
Why?
| | Nasal Decongestants | 1 | 1997 | 8 | 0.140 |
Why?
| | Histamine H1 Antagonists | 1 | 1997 | 24 | 0.130 |
Why?
| | Adolescent | 16 | 2016 | 22428 | 0.130 |
Why?
| | Mydriasis | 1 | 1997 | 10 | 0.130 |
Why?
| | Nerve Agents | 1 | 2017 | 7 | 0.130 |
Why?
| | Atropine | 1 | 2017 | 37 | 0.130 |
Why?
| | Gestational Age | 6 | 2017 | 975 | 0.130 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 124 | 0.130 |
Why?
| | Conjunctiva | 1 | 2017 | 53 | 0.130 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.130 |
Why?
| | Meningitis | 3 | 1983 | 80 | 0.130 |
Why?
| | Athletic Injuries | 3 | 1989 | 569 | 0.130 |
Why?
| | Antimetabolites | 1 | 1997 | 21 | 0.130 |
Why?
| | Synovitis | 1 | 2017 | 33 | 0.130 |
Why?
| | Drug Therapy, Combination | 5 | 2012 | 1047 | 0.130 |
Why?
| | Adult | 21 | 2018 | 40449 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 1999 | 335 | 0.120 |
Why?
| | Retrospective Studies | 15 | 2021 | 17066 | 0.120 |
Why?
| | Cicatrix | 1 | 1997 | 69 | 0.120 |
Why?
| | Orbital Neoplasms | 2 | 1993 | 27 | 0.120 |
Why?
| | Swine | 1 | 2019 | 833 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 412 | 0.120 |
Why?
| | False Positive Reactions | 2 | 2011 | 121 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 3 | 1982 | 113 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 583 | 0.120 |
Why?
| | Fluorouracil | 1 | 1997 | 235 | 0.120 |
Why?
| | Health Personnel | 2 | 2000 | 748 | 0.120 |
Why?
| | Uveitis | 1 | 2017 | 148 | 0.120 |
Why?
| | Antidotes | 1 | 2017 | 145 | 0.120 |
Why?
| | Educational Measurement | 1 | 2019 | 326 | 0.120 |
Why?
| | Afghanistan | 2 | 2007 | 96 | 0.110 |
Why?
| | Convergence, Ocular | 1 | 1995 | 6 | 0.110 |
Why?
| | Visual Fields | 3 | 2007 | 115 | 0.110 |
Why?
| | Treatment Outcome | 10 | 2011 | 11679 | 0.110 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.110 |
Why?
| | Fibrosis | 1 | 2017 | 548 | 0.110 |
Why?
| | Eye Burns | 1 | 2015 | 14 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 319 | 0.110 |
Why?
| | Public Health | 1 | 2000 | 566 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 32 | 0.110 |
Why?
| | Ethanol | 1 | 1999 | 627 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1837 | 0.110 |
Why?
| | Quality of Health Care | 1 | 1999 | 691 | 0.110 |
Why?
| | Interleukin-8 | 3 | 2021 | 271 | 0.110 |
Why?
| | Animals | 9 | 2021 | 38058 | 0.110 |
Why?
| | Keratitis | 2 | 2017 | 20 | 0.100 |
Why?
| | Slit Lamp | 1 | 2014 | 3 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 6 | 2010 | 3863 | 0.100 |
Why?
| | Hyphema | 1 | 2013 | 6 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2019 | 557 | 0.100 |
Why?
| | Keratotomy, Radial | 1 | 1993 | 10 | 0.100 |
Why?
| | Lymphangioma | 1 | 1993 | 9 | 0.100 |
Why?
| | Health Care Surveys | 2 | 2010 | 539 | 0.100 |
Why?
| | Blindness | 2 | 2009 | 52 | 0.100 |
Why?
| | Scleral Diseases | 1 | 1992 | 2 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1098 | 0.100 |
Why?
| | Staphylococcus | 2 | 2011 | 74 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 430 | 0.100 |
Why?
| | Abducens Nerve | 1 | 1992 | 3 | 0.090 |
Why?
| | Skull Neoplasms | 1 | 1992 | 21 | 0.090 |
Why?
| | Dura Mater | 1 | 1992 | 35 | 0.090 |
Why?
| | Eye Infections, Fungal | 1 | 1992 | 19 | 0.090 |
Why?
| | Anesthetics, Dissociative | 1 | 2012 | 46 | 0.090 |
Why?
| | Opportunistic Infections | 1 | 1992 | 45 | 0.090 |
Why?
| | Glucocorticoids | 4 | 2017 | 535 | 0.090 |
Why?
| | Cranial Nerve Diseases | 1 | 1992 | 43 | 0.090 |
Why?
| | Hospitals, Military | 3 | 2007 | 31 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4271 | 0.090 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.090 |
Why?
| | Paralysis | 1 | 1992 | 67 | 0.090 |
Why?
| | Child Abuse | 3 | 2013 | 551 | 0.090 |
Why?
| | Craniocerebral Trauma | 3 | 2013 | 176 | 0.090 |
Why?
| | Foreign Bodies | 1 | 2013 | 107 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2011 | 5408 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2011 | 2029 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2003 | 266 | 0.080 |
Why?
| | Vision, Binocular | 4 | 2005 | 47 | 0.080 |
Why?
| | Ketamine | 1 | 2012 | 132 | 0.080 |
Why?
| | Silymarin | 1 | 2012 | 147 | 0.080 |
Why?
| | Anisometropia | 1 | 2011 | 18 | 0.080 |
Why?
| | Hyperopia | 1 | 2011 | 19 | 0.080 |
Why?
| | Orbital Cellulitis | 1 | 2011 | 17 | 0.080 |
Why?
| | Facial Pain | 1 | 1990 | 12 | 0.080 |
Why?
| | Gingivitis | 1 | 1990 | 13 | 0.080 |
Why?
| | Drug Industry | 1 | 1990 | 49 | 0.080 |
Why?
| | Middle Aged | 13 | 2016 | 35875 | 0.080 |
Why?
| | Corneal Keratocytes | 2 | 2021 | 8 | 0.080 |
Why?
| | Malpractice | 1 | 2010 | 44 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 372 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 1990 | 29 | 0.080 |
Why?
| | Retina | 3 | 2021 | 324 | 0.080 |
Why?
| | Immunoglobulin Light Chains | 1 | 1990 | 51 | 0.080 |
Why?
| | Light | 1 | 2013 | 411 | 0.080 |
Why?
| | Aged | 13 | 2016 | 25913 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2013 | 340 | 0.080 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 1907 | 0.070 |
Why?
| | Incidental Findings | 1 | 2010 | 80 | 0.070 |
Why?
| | Aerospace Medicine | 3 | 2014 | 33 | 0.070 |
Why?
| | Fluorescein Angiography | 4 | 1999 | 189 | 0.070 |
Why?
| | Retinal Vessels | 1 | 1990 | 77 | 0.070 |
Why?
| | Anti-Infective Agents | 2 | 2002 | 242 | 0.070 |
Why?
| | Nocardia Infections | 1 | 1989 | 11 | 0.070 |
Why?
| | Incidence | 4 | 2013 | 2879 | 0.070 |
Why?
| | Corneal Ulcer | 2 | 2004 | 20 | 0.070 |
Why?
| | Blood Vessels | 2 | 2021 | 171 | 0.070 |
Why?
| | Color Perception Tests | 1 | 2007 | 3 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 396 | 0.070 |
Why?
| | Enteral Nutrition | 1 | 1990 | 216 | 0.070 |
Why?
| | Autopsy | 1 | 2007 | 94 | 0.070 |
Why?
| | Urinary Tract Infections | 2 | 1987 | 202 | 0.070 |
Why?
| | Sudden Infant Death | 1 | 2007 | 39 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 846 | 0.060 |
Why?
| | Fundus Oculi | 6 | 1994 | 89 | 0.060 |
Why?
| | Eye Movements | 3 | 2005 | 92 | 0.060 |
Why?
| | Shaken Baby Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
| | Accidents, Traffic | 2 | 2013 | 190 | 0.060 |
Why?
| | Chromosome Inversion | 1 | 1986 | 19 | 0.060 |
Why?
| | Prevalence | 2 | 2013 | 2834 | 0.060 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1986 | 50 | 0.060 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2006 | 11 | 0.060 |
Why?
| | Nasolacrimal Duct | 1 | 2006 | 12 | 0.060 |
Why?
| | Videotape Recording | 1 | 1986 | 37 | 0.060 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2017 | 73 | 0.060 |
Why?
| | Lasers, Excimer | 1 | 2006 | 30 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2006 | 47 | 0.060 |
Why?
| | Optic Nerve Diseases | 1 | 2006 | 49 | 0.060 |
Why?
| | Time Factors | 4 | 2017 | 7173 | 0.060 |
Why?
| | Health Surveys | 2 | 2006 | 518 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 1985 | 30 | 0.060 |
Why?
| | Skin Diseases, Infectious | 1 | 1985 | 13 | 0.060 |
Why?
| | Cell Survival | 2 | 2021 | 1098 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 1986 | 162 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1489 | 0.060 |
Why?
| | Quality Control | 1 | 2006 | 163 | 0.060 |
Why?
| | Tomography, Optical Coherence | 1 | 2007 | 271 | 0.060 |
Why?
| | Colorado | 4 | 2017 | 4564 | 0.060 |
Why?
| | Smoking Prevention | 1 | 1986 | 166 | 0.060 |
Why?
| | Refractive Surgical Procedures | 1 | 2005 | 7 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1992 | 928 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 974 | 0.060 |
Why?
| | Pyoderma | 1 | 1984 | 3 | 0.050 |
Why?
| | Reoperation | 3 | 1999 | 630 | 0.050 |
Why?
| | Ethics | 1 | 2004 | 4 | 0.050 |
Why?
| | Night Blindness | 1 | 2004 | 6 | 0.050 |
Why?
| | Myxoma | 1 | 1984 | 11 | 0.050 |
Why?
| | Xerophthalmia | 1 | 2004 | 7 | 0.050 |
Why?
| | Mitral Valve Stenosis | 1 | 1984 | 20 | 0.050 |
Why?
| | Intellectual Disability | 1 | 1986 | 175 | 0.050 |
Why?
| | Organizational Objectives | 1 | 2004 | 66 | 0.050 |
Why?
| | Heart Neoplasms | 1 | 1984 | 55 | 0.050 |
Why?
| | Chloramphenicol | 1 | 1983 | 10 | 0.050 |
Why?
| | Theophylline | 1 | 1984 | 41 | 0.050 |
Why?
| | Ampicillin | 1 | 1983 | 15 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 1986 | 233 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 372 | 0.050 |
Why?
| | Esophageal Diseases | 1 | 1984 | 30 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2005 | 310 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1716 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 474 | 0.050 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2003 | 26 | 0.050 |
Why?
| | Drug Packaging | 1 | 2003 | 41 | 0.050 |
Why?
| | Syndrome | 3 | 2020 | 380 | 0.050 |
Why?
| | Corneal Opacity | 2 | 2016 | 8 | 0.050 |
Why?
| | Pleura | 1 | 1983 | 28 | 0.050 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 1983 | 12 | 0.050 |
Why?
| | Cholestasis | 1 | 1985 | 219 | 0.050 |
Why?
| | Illinois | 2 | 2000 | 47 | 0.050 |
Why?
| | Counseling | 1 | 1986 | 408 | 0.050 |
Why?
| | Femoral Fractures | 2 | 1992 | 82 | 0.050 |
Why?
| | Cross Infection | 1 | 1985 | 262 | 0.050 |
Why?
| | Methylprednisolone | 1 | 2003 | 64 | 0.050 |
Why?
| | Drug Combinations | 2 | 1997 | 390 | 0.050 |
Why?
| | Citrobacter | 1 | 1982 | 3 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2010 | 1356 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2005 | 338 | 0.050 |
Why?
| | Abducens Nerve Injury | 1 | 2002 | 1 | 0.050 |
Why?
| | Oculomotor Nerve Injuries | 1 | 2002 | 2 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 1983 | 112 | 0.040 |
Why?
| | Cohort Studies | 3 | 2017 | 5960 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 1982 | 41 | 0.040 |
Why?
| | Radiography, Thoracic | 1 | 1983 | 171 | 0.040 |
Why?
| | Young Adult | 2 | 2016 | 14105 | 0.040 |
Why?
| | Pectoralis Muscles | 1 | 1981 | 17 | 0.040 |
Why?
| | Electroretinography | 1 | 2021 | 50 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1982 | 111 | 0.040 |
Why?
| | Tibial Fractures | 1 | 1982 | 72 | 0.040 |
Why?
| | Parents | 2 | 2006 | 1403 | 0.040 |
Why?
| | Medical Records | 1 | 2001 | 187 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2003 | 780 | 0.040 |
Why?
| | Infant, Premature | 2 | 2017 | 611 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2925 | 0.040 |
Why?
| | Steroids | 1 | 2001 | 160 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 585 | 0.040 |
Why?
| | Cataract | 1 | 2003 | 238 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 221 | 0.040 |
Why?
| | Appendicitis | 1 | 1982 | 148 | 0.040 |
Why?
| | Acute Disease | 2 | 2019 | 1030 | 0.040 |
Why?
| | Administration, Oral | 2 | 2017 | 847 | 0.040 |
Why?
| | Risk | 3 | 1989 | 911 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 1999 | 69 | 0.040 |
Why?
| | Chlorambucil | 1 | 1999 | 10 | 0.040 |
Why?
| | Vitreous Hemorrhage | 1 | 1999 | 10 | 0.040 |
Why?
| | Colon | 1 | 1982 | 304 | 0.040 |
Why?
| | Leukemia | 1 | 1981 | 245 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2005 | 621 | 0.040 |
Why?
| | Sodium Chloride | 1 | 1999 | 141 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 4 | 1999 | 2730 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 1982 | 332 | 0.030 |
Why?
| | Corneal Pachymetry | 1 | 2017 | 16 | 0.030 |
Why?
| | Lens, Crystalline | 1 | 1999 | 136 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 1999 | 177 | 0.030 |
Why?
| | Prednisone | 1 | 1999 | 221 | 0.030 |
Why?
| | Blister | 1 | 2017 | 39 | 0.030 |
Why?
| | Risk Assessment | 2 | 2017 | 3671 | 0.030 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2017 | 93 | 0.030 |
Why?
| | Hereditary Autoinflammatory Diseases | 1 | 2017 | 13 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 142 | 0.030 |
Why?
| | Brain | 1 | 2010 | 2933 | 0.030 |
Why?
| | Optometry | 1 | 1997 | 9 | 0.030 |
Why?
| | Bone Marrow | 1 | 1999 | 304 | 0.030 |
Why?
| | Intraoperative Period | 1 | 1997 | 69 | 0.030 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 34 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 198 | 0.030 |
Why?
| | Body Weight | 1 | 2001 | 976 | 0.030 |
Why?
| | Quality of Life | 2 | 2006 | 3185 | 0.030 |
Why?
| | Administration, Topical | 1 | 1997 | 150 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 77 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 24 | 0.030 |
Why?
| | Battered Child Syndrome | 2 | 1992 | 7 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1560 | 0.030 |
Why?
| | Rupture | 1 | 2016 | 91 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 154 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 162 | 0.030 |
Why?
| | Apoptosis | 2 | 2016 | 2430 | 0.030 |
Why?
| | Prognosis | 3 | 2020 | 4282 | 0.030 |
Why?
| | Eye | 1 | 2016 | 109 | 0.030 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1995 | 8 | 0.030 |
Why?
| | Sarcoidosis | 1 | 2017 | 160 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1994 | 19 | 0.030 |
Why?
| | Scotoma | 1 | 1994 | 6 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 1994 | 13 | 0.030 |
Why?
| | Choroid Diseases | 1 | 1994 | 10 | 0.030 |
Why?
| | Choroiditis | 1 | 1994 | 6 | 0.030 |
Why?
| | Pilot Projects | 1 | 2000 | 1886 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 279 | 0.030 |
Why?
| | Accidents, Home | 1 | 2013 | 33 | 0.030 |
Why?
| | Ophthalmoplegia | 1 | 1993 | 13 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1993 | 47 | 0.020 |
Why?
| | Contraindications | 1 | 1993 | 91 | 0.020 |
Why?
| | Facial Paralysis | 1 | 1993 | 23 | 0.020 |
Why?
| | Tamoxifen | 1 | 1994 | 217 | 0.020 |
Why?
| | Blotting, Western | 1 | 2016 | 1187 | 0.020 |
Why?
| | Iris | 1 | 1993 | 24 | 0.020 |
Why?
| | Dark Adaptation | 1 | 2013 | 13 | 0.020 |
Why?
| | Aviation | 1 | 2013 | 10 | 0.020 |
Why?
| | Surgery, Plastic | 1 | 1994 | 52 | 0.020 |
Why?
| | Fungemia | 1 | 1992 | 10 | 0.020 |
Why?
| | Ocular Physiological Phenomena | 1 | 1992 | 10 | 0.020 |
Why?
| | Cranial Fossa, Posterior | 1 | 1992 | 20 | 0.020 |
Why?
| | Aspergillosis | 1 | 1992 | 23 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1347 | 0.020 |
Why?
| | Candidiasis | 1 | 1992 | 64 | 0.020 |
Why?
| | Irritants | 1 | 2012 | 38 | 0.020 |
Why?
| | Eye Diseases | 1 | 1993 | 94 | 0.020 |
Why?
| | Emergencies | 2 | 2009 | 175 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 681 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 244 | 0.020 |
Why?
| | Mycoses | 1 | 1992 | 88 | 0.020 |
Why?
| | Vision Disparity | 1 | 1991 | 3 | 0.020 |
Why?
| | Vision Disorders | 1 | 1993 | 178 | 0.020 |
Why?
| | Radiography | 3 | 1985 | 844 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2027 | 0.020 |
Why?
| | Thrombocytopenia | 1 | 2013 | 205 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2018 | 696 | 0.020 |
Why?
| | Sex Factors | 3 | 1987 | 2112 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1047 | 0.020 |
Why?
| | Coloboma | 1 | 1990 | 5 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 1990 | 36 | 0.020 |
Why?
| | Retinal Perforations | 1 | 1990 | 18 | 0.020 |
Why?
| | Safflower Oil | 1 | 1990 | 4 | 0.020 |
Why?
| | Crohn Disease | 1 | 1994 | 260 | 0.020 |
Why?
| | Light Coagulation | 1 | 1990 | 10 | 0.020 |
Why?
| | Soybean Oil | 1 | 1990 | 15 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2005 | 8265 | 0.020 |
Why?
| | Emulsions | 1 | 1990 | 57 | 0.020 |
Why?
| | Sacroiliac Joint | 2 | 1994 | 37 | 0.020 |
Why?
| | HEPES | 1 | 1989 | 2 | 0.020 |
Why?
| | Chondroitin | 1 | 1989 | 6 | 0.020 |
Why?
| | Tissue Preservation | 1 | 1989 | 12 | 0.020 |
Why?
| | Propionibacterium acnes | 1 | 1989 | 10 | 0.020 |
Why?
| | Lung | 1 | 1983 | 4109 | 0.020 |
Why?
| | Chondroitin Sulfates | 1 | 1989 | 35 | 0.020 |
Why?
| | Graft Rejection | 1 | 1992 | 540 | 0.020 |
Why?
| | Nocardia asteroides | 1 | 1989 | 1 | 0.020 |
Why?
| | Sulfacetamide | 1 | 1989 | 1 | 0.020 |
Why?
| | Trimethoprim | 1 | 1989 | 7 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 1989 | 7 | 0.020 |
Why?
| | Gentamicins | 1 | 1989 | 51 | 0.020 |
Why?
| | Indians, North American | 1 | 1995 | 647 | 0.020 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1989 | 42 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 1993 | 514 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 549 | 0.020 |
Why?
| | Phospholipids | 1 | 1990 | 213 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2496 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1821 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1990 | 216 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2007 | 17 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 722 | 0.020 |
Why?
| | Brain Injuries | 1 | 1992 | 507 | 0.020 |
Why?
| | Orbit Evisceration | 1 | 2006 | 1 | 0.020 |
Why?
| | Recurrence | 1 | 1990 | 1135 | 0.020 |
Why?
| | Forensic Pathology | 1 | 2006 | 8 | 0.020 |
Why?
| | Piperazines | 1 | 1989 | 381 | 0.020 |
Why?
| | Dacryocystorhinostomy | 1 | 2006 | 13 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2006 | 62 | 0.020 |
Why?
| | Hawaii | 1 | 1986 | 46 | 0.020 |
Why?
| | Chromosome Disorders | 1 | 1986 | 45 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1986 | 166 | 0.010 |
Why?
| | Mutation | 1 | 2017 | 4089 | 0.010 |
Why?
| | Klebsiella pneumoniae | 1 | 1985 | 47 | 0.010 |
Why?
| | Wounds, Nonpenetrating | 1 | 2009 | 316 | 0.010 |
Why?
| | Informed Consent | 1 | 1986 | 198 | 0.010 |
Why?
| | Hirschsprung Disease | 1 | 1985 | 91 | 0.010 |
Why?
| | Tablets | 1 | 1984 | 41 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 1983 | 8 | 0.010 |
Why?
| | Ulcer | 1 | 1984 | 37 | 0.010 |
Why?
| | Abdominal Muscles | 1 | 1983 | 11 | 0.010 |
Why?
| | Meningitis, Haemophilus | 1 | 1983 | 6 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1985 | 72 | 0.010 |
Why?
| | Mitral Valve | 1 | 1984 | 96 | 0.010 |
Why?
| | Hernia, Umbilical | 1 | 1983 | 21 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1992 | 1169 | 0.010 |
Why?
| | Haemophilus influenzae | 1 | 1983 | 67 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1337 | 0.010 |
Why?
| | Health Services Misuse | 1 | 1983 | 36 | 0.010 |
Why?
| | Angiostrongylus | 1 | 1982 | 1 | 0.010 |
Why?
| | Nematode Infections | 1 | 1982 | 5 | 0.010 |
Why?
| | Age Distribution | 1 | 2003 | 403 | 0.010 |
Why?
| | Infant, Premature, Diseases | 1 | 1983 | 111 | 0.010 |
Why?
| | Feces | 1 | 1985 | 513 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1306 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 1982 | 15 | 0.010 |
Why?
| | Contracture | 1 | 1982 | 23 | 0.010 |
Why?
| | Kidney | 1 | 1990 | 1495 | 0.010 |
Why?
| | Leukemia, Lymphoid | 1 | 1981 | 27 | 0.010 |
Why?
| | Enema | 1 | 1982 | 46 | 0.010 |
Why?
| | Attitude of Health Personnel | 2 | 1987 | 1185 | 0.010 |
Why?
| | Age Factors | 1 | 1989 | 3333 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 74 | 0.010 |
Why?
| | Glucagon | 1 | 1982 | 112 | 0.010 |
Why?
| | Regression Analysis | 1 | 2003 | 1003 | 0.010 |
Why?
| | Skin | 1 | 1985 | 755 | 0.010 |
Why?
| | Hip Joint | 1 | 1982 | 172 | 0.010 |
Why?
| | Contrast Media | 1 | 1982 | 488 | 0.010 |
Why?
| | Knee Joint | 1 | 1982 | 426 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 5868 | 0.010 |
Why?
| | Spasm | 1 | 1994 | 21 | 0.010 |
Why?
| | Spondylitis | 1 | 1994 | 1 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1981 | 682 | 0.010 |
Why?
| | Sulfasalazine | 1 | 1994 | 22 | 0.010 |
Why?
| | Tenosynovitis | 1 | 1994 | 11 | 0.010 |
Why?
| | Crystallization | 1 | 1994 | 145 | 0.010 |
Why?
| | Cadaver | 1 | 1994 | 304 | 0.010 |
Why?
| | Middle East | 1 | 1993 | 18 | 0.010 |
Why?
| | Accommodation, Ocular | 1 | 1993 | 15 | 0.010 |
Why?
| | Rib Fractures | 1 | 1992 | 33 | 0.010 |
Why?
| | Posture | 1 | 1993 | 196 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 333 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 338 | 0.010 |
Why?
| | Reference Values | 1 | 1992 | 797 | 0.010 |
Why?
| | Drug Contamination | 1 | 1989 | 52 | 0.000 |
Why?
| | Postoperative Care | 1 | 1991 | 288 | 0.000 |
Why?
| | Culture Media | 1 | 1989 | 161 | 0.000 |
Why?
| | Macular Degeneration | 1 | 1990 | 191 | 0.000 |
Why?
| | Suppuration | 1 | 1985 | 9 | 0.000 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1985 | 4 | 0.000 |
Why?
| | Gallium Radioisotopes | 1 | 1985 | 15 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1985 | 112 | 0.000 |
Why?
| | Breast Neoplasms | 1 | 1994 | 2452 | 0.000 |
Why?
| | Aging | 1 | 1990 | 1966 | 0.000 |
Why?
| | Pediatrics | 1 | 1987 | 1114 | 0.000 |
Why?
|
|
Enzenauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|